vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and TELOS CORP (TLS). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $46.8M, roughly 1.6× TELOS CORP). On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $8.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 25.7%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

PBYI vs TLS — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.6× larger
PBYI
$75.5M
$46.8M
TLS
Growing faster (revenue YoY)
TLS
TLS
+49.7% gap
TLS
77.4%
27.7%
PBYI
More free cash flow
PBYI
PBYI
$6.4M more FCF
PBYI
$14.4M
$8.0M
TLS
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
25.7%
TLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
TLS
TLS
Revenue
$75.5M
$46.8M
Net Profit
$-16.3M
Gross Margin
69.3%
35.0%
Operating Margin
22.7%
-39.6%
Net Margin
-34.9%
Revenue YoY
27.7%
77.4%
Net Profit YoY
-74.8%
EPS (diluted)
$0.26
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
TLS
TLS
Q4 25
$75.5M
$46.8M
Q3 25
$54.5M
$51.4M
Q2 25
$52.4M
$36.0M
Q1 25
$46.0M
$30.6M
Q4 24
$59.1M
$26.4M
Q3 24
$80.5M
$23.8M
Q2 24
$47.1M
$28.5M
Q1 24
$43.8M
$29.6M
Net Profit
PBYI
PBYI
TLS
TLS
Q4 25
$-16.3M
Q3 25
$8.8M
$-2.1M
Q2 25
$5.9M
$-9.5M
Q1 25
$3.0M
$-8.6M
Q4 24
$-9.3M
Q3 24
$20.3M
$-28.1M
Q2 24
$-4.5M
$-7.8M
Q1 24
$-4.8M
$-7.4M
Gross Margin
PBYI
PBYI
TLS
TLS
Q4 25
69.3%
35.0%
Q3 25
77.7%
39.9%
Q2 25
76.5%
33.2%
Q1 25
77.1%
39.8%
Q4 24
76.4%
40.3%
Q3 24
63.9%
13.2%
Q2 24
77.4%
34.1%
Q1 24
75.5%
37.0%
Operating Margin
PBYI
PBYI
TLS
TLS
Q4 25
22.7%
-39.6%
Q3 25
17.6%
-4.8%
Q2 25
12.7%
-27.5%
Q1 25
8.7%
-29.5%
Q4 24
22.6%
-37.6%
Q3 24
27.4%
-121.4%
Q2 24
-4.6%
-30.3%
Q1 24
-5.3%
-28.5%
Net Margin
PBYI
PBYI
TLS
TLS
Q4 25
-34.9%
Q3 25
16.2%
-4.1%
Q2 25
11.2%
-26.5%
Q1 25
6.5%
-28.1%
Q4 24
-35.4%
Q3 24
25.2%
-118.0%
Q2 24
-9.6%
-27.2%
Q1 24
-11.0%
-24.9%
EPS (diluted)
PBYI
PBYI
TLS
TLS
Q4 25
$0.26
$-0.22
Q3 25
$0.17
$-0.03
Q2 25
$0.12
$-0.13
Q1 25
$0.06
$-0.12
Q4 24
$0.40
$-0.13
Q3 24
$0.41
$-0.39
Q2 24
$-0.09
$-0.11
Q1 24
$-0.10
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$97.5M
$53.2M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$96.0M
Total Assets
$216.3M
$139.9M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
TLS
TLS
Q4 25
$97.5M
$53.2M
Q3 25
$94.4M
$59.0M
Q2 25
$96.0M
$57.0M
Q1 25
$93.2M
$57.8M
Q4 24
$101.0M
$54.6M
Q3 24
$96.7M
$69.8M
Q2 24
$96.8M
$80.1M
Q1 24
$107.2M
$93.9M
Total Debt
PBYI
PBYI
TLS
TLS
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
TLS
TLS
Q4 25
$130.3M
$96.0M
Q3 25
$115.3M
$119.7M
Q2 25
$104.7M
$118.4M
Q1 25
$97.1M
$126.1M
Q4 24
$92.1M
$127.1M
Q3 24
$71.1M
$129.5M
Q2 24
$48.5M
$149.1M
Q1 24
$51.0M
$154.4M
Total Assets
PBYI
PBYI
TLS
TLS
Q4 25
$216.3M
$139.9M
Q3 25
$202.9M
$164.3M
Q2 25
$194.9M
$165.0M
Q1 25
$196.2M
$158.1M
Q4 24
$213.3M
$158.2M
Q3 24
$220.7M
$166.3M
Q2 24
$205.0M
$182.4M
Q1 24
$214.1M
$195.4M
Debt / Equity
PBYI
PBYI
TLS
TLS
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
TLS
TLS
Operating Cash FlowLast quarter
$14.4M
$8.0M
Free Cash FlowOCF − Capex
$14.4M
$8.0M
FCF MarginFCF / Revenue
19.1%
17.0%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
TLS
TLS
Q4 25
$14.4M
$8.0M
Q3 25
$9.7M
$9.1M
Q2 25
$14.1M
$7.0M
Q1 25
$3.6M
$6.1M
Q4 24
$15.6M
$-10.5M
Q3 24
$11.0M
$-7.1M
Q2 24
$1.0M
$-8.0M
Q1 24
$11.2M
$-350.0K
Free Cash Flow
PBYI
PBYI
TLS
TLS
Q4 25
$14.4M
$8.0M
Q3 25
$9.7M
$8.7M
Q2 25
$14.1M
$6.8M
Q1 25
$3.6M
$6.0M
Q4 24
$15.6M
$-12.4M
Q3 24
$11.0M
$-7.1M
Q2 24
$1.0M
$-8.2M
Q1 24
$-447.0K
FCF Margin
PBYI
PBYI
TLS
TLS
Q4 25
19.1%
17.0%
Q3 25
17.7%
16.9%
Q2 25
26.8%
19.0%
Q1 25
7.7%
19.5%
Q4 24
26.4%
-47.0%
Q3 24
13.7%
-30.0%
Q2 24
2.1%
-28.9%
Q1 24
-1.5%
Capex Intensity
PBYI
PBYI
TLS
TLS
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.9%
Q2 25
0.0%
0.4%
Q1 25
0.1%
0.4%
Q4 24
0.0%
7.1%
Q3 24
0.0%
0.2%
Q2 24
0.0%
0.8%
Q1 24
0.0%
0.3%
Cash Conversion
PBYI
PBYI
TLS
TLS
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons